- Q1 2024 BioArctic AB Earnings Call TranscriptMay 17, 2024kr232.6 (+0.56%)Earnings
- Q4 2023 BioArctic AB Earnings Call TranscriptFeb 14, 2024kr216 (+6.06%)Earnings
- Q3 2023 BioArctic AB Earnings Call TranscriptNov 08, 2023kr211.3 (-3.30%)Earnings
- Q2 2023 BioArctic AB Earnings Call TranscriptJul 12, 2023kr291.7 (-0.95%)Earnings
- Q1 2023 BioArctic AB Earnings Call TranscriptApr 27, 2023kr254.5 (+8.62%)Earnings
- Q4 2022 BioArctic AB Earnings Call TranscriptFeb 03, 2023kr294.7 (-1.96%)Earnings
- Q3 2022 BioArctic AB Earnings Call TranscriptOct 20, 2022kr251.5 (+4.92%)Earnings
- Q2 2022 BioArctic AB Earnings Call TranscriptJul 12, 2022kr79.53 (-2.45%)Earnings
- Q1 2022 BioArctic AB Earnings Call TranscriptApr 28, 2022kr72.68 (-7.86%)Earnings
- Q4 2021 BioArctic AB Earnings Call TranscriptFeb 03, 2022kr110.3 (-0.90%)Earnings
- Q3 2021 BioArctic AB Earnings Call TranscriptOct 21, 2021kr142.3 (-1.45%)Earnings
- Q2 2021 BioArctic AB Earnings Call TranscriptJul 09, 2021kr145 (+4.09%)Earnings
- Q1 2021 BioArctic AB Earnings Call TranscriptApr 21, 2021kr91.9 (+3.03%)Earnings
- Full Year 2020 BioArctic AB Earnings Call TranscriptFeb 04, 2021kr99.68 (-0.45%)Earnings
- Nine Months 2020 BioArctic AB Earnings Call TranscriptOct 14, 2020kr88.53 (+1.40%)Earnings
- Q2 2020 BioArctic AB Earnings Call TranscriptJul 10, 2020kr79.95 (+6.67%)Earnings
- Q1 2020 BioArctic AB Earnings Call TranscriptApr 22, 2020kr65.3 (-5.64%)Earnings
- Full Year 2019 BioArctic AB Earnings Call TranscriptFeb 06, 2020kr82.1 (-3.61%)Earnings
- Q3 2019 BioArctic AB Earnings Call TranscriptOct 24, 2019kr90.38Earnings
- Q2 2019 BioArctic AB Earnings Call TranscriptJul 11, 2019kr71.65 (-0.35%)Earnings
- Q1 2019 BioArctic AB Earnings Call TranscriptMay 09, 2019kr74.7 (-0.30%)Earnings
- Full Year 2018 BioArctic AB Earnings Call TranscriptFeb 14, 2019kr97.22 (+2.22%)Earnings
Q3 2023 BioArctic AB Earnings Call Transcript
This call is being recorded. Welcome to the BioArctic Q3 presentation for 2023. (Operator Instructions) Now I will hand the conference over to the CEO, Gunilla Osswald; and CFO, Anders Martin-Lof. Please go ahead.
()-
Good morning, and welcome to BioArctic's presentation for the third quarter of 2023. I'm Gunilla Osswald and I'm the CEO of BioArctic and I will share today's presentation with our CFO, Anders Martin-Lof. I think it's very exciting times for BioArctic with LEQEMBI being the first and only disease-modifying treatment with a full approval in the U.S. and now also in Japan. And both these things happened during this quarter. I think it's beginning of a new era. And BioArctic is behind this true breakthrough in the treatment of Alzheimer's disease. I find this extremely gratifying that we now can help a large number of patients and families around the world. And I'll talk more about that here today.
Next slide, please. BioArctic is listed at Nasdaq Stockholm Large Cap and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)